Your browser doesn't support javascript.
loading
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Dalgleish, Angus G; Stebbing, Justin; Adamson, Douglas Ja; Arif, Seema Safia; Bidoli, Paolo; Chang, David; Cheeseman, Sue; Diaz-Beveridge, Robert; Fernandez-Martos, Carlos; Glynne-Jones, Rob; Granetto, Cristina; Massuti, Bartomeu; McAdam, Karen; McDermott, Raymond; Martín, Andrés J Muñoz; Papamichael, Demetris; Pazo-Cid, Roberto; Vieitez, Jose M; Zaniboni, Alberto; Carroll, Kevin J; Wagle, Shama; Gaya, Andrew; Mudan, Satvinder S.
Afiliação
  • Dalgleish AG; Cancer Vaccine Institute, St George's University of London, London, UK.
  • Stebbing J; Department of Oncology, Imperial College, Hammersmith Hospital, London, UK.
  • Adamson DJ; Department of Oncology, Ninewells Hospital, Dundee, UK.
  • Arif SS; Velindre Cancer Centre, Cardiff, UK.
  • Bidoli P; Department of Oncology, Azienda Ospedaliera San Gerardo, Monza, Italy.
  • Chang D; Department of General Surgery, Royal Blackburn Hospital, Blackburn, UK.
  • Cheeseman S; Department of Oncology, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Diaz-Beveridge R; Médico Adjunto de Oncología Médica, Hospital La Fe de Valencia, Valencia, Spain.
  • Fernandez-Martos C; Instituto Valenciano de Oncologia, Valencia, Spain.
  • Glynne-Jones R; Mount Vernon Cancer Centre, Northwood, UK.
  • Granetto C; Medical Oncology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
  • Massuti B; Ensayos Clínicos Oncología, Hospital General Universitario de Alicante, Alicante, Spain.
  • McAdam K; Oncology Department, Peterborough and Stamford Hospitals NHS Trust, Peterborough, UK.
  • McDermott R; Medical Oncology, St Vincent's University Hospital and The Adelaide and Meath Hospital, Dublin, Republic of Ireland.
  • Martín AJ; Gastrointestinal Cancer Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Papamichael D; Department of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
  • Pazo-Cid R; Servicio de Oncología Médica, Hospital Miguel Servet, Zaragoza, Spain.
  • Vieitez JM; Area and Neuroendocrine Tumors Gastrointestinal Medical Oncology, Hospital Central de Asturias, Asturias, Spain.
  • Zaniboni A; Oncology Department, Fondazione Poliambulanza, Brescia, Italy.
  • Carroll KJ; TranScrip Partners LLP, Reading, UK.
  • Wagle S; TranScrip Partners LLP, Reading, UK.
  • Gaya A; Clinical Oncology, Guy's & St Thomas' Hospitals NHS Trust, London, UK.
  • Mudan SS; St George's University of London, Imperial College, London and The Royal Marsden Hospital, London, UK.
Br J Cancer ; 115(7): 789-96, 2016 09 27.
Article em En | MEDLINE | ID: mdl-27599039
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Imunoterapia Ativa / Vacinas Anticâncer / Carcinoma Ductal Pancreático / Desoxicitidina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Imunoterapia Ativa / Vacinas Anticâncer / Carcinoma Ductal Pancreático / Desoxicitidina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article